4503 — Astellas Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual balance sheet for Astellas Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	318,267	376,946	335,780	189,876	291,177
Net Total Accounts Receivable
Net Total Receivables	423,018	465,455	576,726	674,653	761,763
Total Inventory
Total Other Current Assets
Total Current Assets	923,354	1,049,954	1,194,730	1,201,349	1,421,923
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	269,044	286,459	293,742	328,921	358,424
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,332,395	2,456,518	3,569,603	3,339,544	3,567,042
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	687,411	726,034	1,285,725	1,061,610	1,218,401
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	872,087	948,564	1,973,615	1,826,289	1,737,998
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,460,308	1,507,954	1,595,988	1,513,255	1,829,044
Total Liabilities & Shareholders' Equity	2,332,395	2,456,518	3,569,603	3,339,544	3,567,042
Total Common Shares Outstanding